St. Jude Children's Research Hospital scientists have discovered how tumors disable immune "gatekeeper" cells that alert the rest of the immune system to the presence of cancer—and how restoring their ...
In solid tumours, such as breast and colon cancers, dendritic cells are not only rare but also defective. Without functional ...
April 02, 2026) St. Jude Children's Research Hospital scientists have discovered how tumors disable immune "gatekeeper" cells that ...
Engineered immune cells spark cancer immunotherapy hope, following metabolic by-products secreted by cancer cells to ...
Cancer treatment is undergoing a major transformation driven by advances in precision oncology, in which biomarkers play a central role in guiding ...
Morning Overview on MSN
Scientists image the immune system’s earliest response inside cells
Macrophages, the immune system’s front-line scavenger cells, do more than simply digest dead cells. A new study published in ...
Leucine-rich repeat kinase 2 (LRRK2) has emerged as a critical player in both neurological and peripheral diseases. In a ...
A research team from the Johns Hopkins Kimmel Cancer Center, its Bloomberg~Kimmel Institute for Cancer Immunotherapy and the ...
A research team from the Johns Hopkins Kimmel Cancer Center, its Bloomberg~Kimmel Institute for Cancer Immunotherapy and the ...
Using a variety of laboratory and animal models, the team found that cysteine fuels the production of the antioxidant ...
Trethera Corporation (“Trethera”), a clinical stage biopharmaceutical company developing first-in-class therapies for cancer, ...
Strengthened financial position through disciplined cost management, with a year-end 2025 cash position of $14.7 million and runway into ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results